Current Drug Targets - Infectious Disorders

Antiretroviral Therapy Regimens for Neuro-AIDS
pp. 187-192(6)
Authors: Arendt, G.; von Giesen, H.J.

Pandemic of Atopic Diseases - A Lack of Microbial Exposure in Early Infancy?
pp. 193-199(7)
Authors: Kalliomaki, M.; Isolauri, E.

Strategic Targeting of Essential Host-pathogen Interactions in Chlamydial Disease
pp. 201-216(16)
Authors: Coombes, B.K.; Johnson, D.L.; Mahony, J.B.

Structure-Based Inhibitor Design Targeting HIV-1 Integrase
pp. 217-234(18)
Authors: Chen, I-J.; Neamati, N.; MacKerell Jr., A.D.

Histidine Kinase-mediated Signal Transduction Systems of Pathogenic Microorganisms as Targets for Therapeutic Intervention
pp. 235-246(12)
Authors: Stephenson, K.; Hoch, J.A.

The Role of the Cytoskeleton in the Life Cycle of Viruses and Intracellular Bacteria: Tracks, Motors, and Polymerization Machines
pp. 247-264(18)
Authors: Bearer, E.L.; Satpute-Krishnan, P.

CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection
pp. 265-278(14)
Authors: Kazmierski, W.M.; Boone, L.; Lawrence, W.; Watson, C.; Kenakin, T.